Chemed Corp

Chemed Corp(CHE)股票分析

$518.710

-4.617 (-0.89%)收盘时

Loading chart…
High
523.700
Open
522.330
VWAP
519.90
Vol
96.65K
Mkt Cap
8.22B
Low
517.290
Amount
50.25M
EV/EBITDA, TTM
15.90

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

AI analysis of Chemed Corp (CHE)

hold

Chemed Corp is currently trading at $523.38, which is below the analyst price target range of $510 to $590. However, the stock has an RSI of 35.22, indicating it may be oversold, and a forward P/E ratio of 22.17 suggests it is fairly valued compared to its growth prospects. The main risk is the significant insider selling, which has increased by 158.47% over the last quarter, indicating potential lack of confidence from insiders.

Analyst Ratings (4)

+5.52% upside
Hold
1 Buy
3 Hold
0 Sell
Current: 518.71
最低
475.00
平均
547.33
最高
595.00

Oppenheimer

2026-07-31

目标价

$590

Outperform

RBC Capital

2026-07-30

目标价

$548

Sector Perform

BofA

2026-07-09

目标价

$510

Neutral

RBC Capital

2026-04-27

目标价

$436

Sector Perform

RBC Capital

2026-02-27

目标价

$422

Sector Perform

估值指标

The current forward P/E ratio for Chemed Corp (CHE) is 21.05, compared to its 5-year average forward P/E of 22.95.

Forward P/E

Fair
5Y Average P/E
22.95
Current P/E
21.05
高估
25.71
低估
20.19

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
15.67
Current EV/EBITDA
15.90
高估
17.44
低估
13.90

Forward P/S

Undervalued
5Y Average P/S
3.12
Current P/S
2.37
高估
3.64
低估
2.60

Alphio AI Price Scenarios for CHE

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CHE

$709.68

情景价格

B

Base

Base · 50%CHE

$700.04

情景价格

B

Bear

Bear · 25%CHE

$601.39

情景价格

Whales holding CHE

A

Aptus Capital Advisors, LLC

+ HoldingCHE

+0.48%

3M Return

事件时间线

2026-08-06 (ET)

12:00:00

Chemed Corporation Declares Quarterly Cash Dividend of $0.70 per Share

2026-07-28 (ET)

16:30:00

Company Revises Guidance, Expected EPS at $24.34

16:30:00

Company Reports Q2 Revenue of $673.25M, Beating Consensus

2026-04-23 (ET)

16:30:00

VITAS Raises 2026 Earnings Guidance to $24.00 to $24.75 per Share

资讯

CHE FAQ — answered by Alphio AI

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Chemed Corp is currently trading at $523.38, which is below the analyst price target range of $510 to $590. However, the stock has an RSI of 35.22, indicating it may be oversold, and a forward P/E ratio of 22.17 suggests it is fairly valued compared to its growth prospects. The main risk is the significant insider selling, which has increased by 158.47% over the last quarter, indicating potential lack of confidence from insiders.

4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始